Home
  • Our Company
    • Biopharmaceutical Acceleration Model®
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Health Economics and Outcomes Research
      • Integrated Commercial Solutions
      • Medical Affairs Transformation
      • Medical Communications
      • Medication Engagement
      • Policy and Advocacy
      • Portfolio Strategy
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Selling Solutions
      • Syndicated Market Research and Insights
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Medical Affairs
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
      • Ophthalmology
      • Respiratory
      • Women's Health
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series Remote Care
Trends

Remote Care

December 1, 2020
Content 

 

Subscribe to our Newsletter

Remote Care

2021 Health Trends
Columns 
Content 
Image or Video 

Trends_2021_01.png

2021 Health Trends Remote Care
Content 

When the pandemic took hold, practices and research sites limited physical access to protect people while health systems and industry partners moved to rapidly scale digital and voice channels to maximize patient connectivity. Regulators and payers joined the cause to reduce friction and fuel reimbursement.

 

Even as that immediacy and urgency fade, healthcare leaders and patients alike have a changed expectation for a future that pivots off a connection, not an office or site. As we enter 2021, the rise, fall and reset of remote monitoring and commercial telemedicine will largely shape the future of care and drive how life sciences leaders engage and support patients and prescribers.  

Critical Questions
  • What will the new best practices be for how industry can support patients and professionals connecting across distance?
  • How can this new fluency consistently create access to trials for more patients and access to support for more patients?
     

Learn more - Download the full Remote Care trend analysis below.

Remote Care Sparks
Columns 
Content 
Image or Video 

01_RemoteCare_01_v2.png

Remote Care Spark 1

300%: The number of practices offering telemedicine connectivity in the U.S. grew from 59% to 76% ​at the height of the 2020 wave of the pandemic.​

– Syneos Health, 2020​

Content 
Image or Video 

01_RemoteCare_02_v2.png

Remote Care Spark 2

Family Teledoc: The healthcare division of Chinese e-commerce giant JD.com recently launched a new service package ​that looks more like a traditional primary care program. ​As many as eight family members share a family doctor ​package that includes 24/7 immediate medical support from GPs and specialist medical consults within 48 hours.

– MobiHealthNews, 2020​

 

Learn More: Download the full Remote Care trend analysis below. 

 

The 2021 Health Trends Series
Implementing Remote Clinical Trial Monitoring to Ensure Continuity of Trials and Data Preservation – While Keeping Patients Safe
Download
Download

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Related Content

The 2021 Health Trends Series
December 1, 2020
Implementing Remote Clinical Trial Monitoring to Ensure Continuity of Trials and Data Preservation – While Keeping Patients Safe
April 3, 2020
Telemedicine Use and Field Force Engagement in the COVID-19 Era and Beyond
June 19, 2020

Chapters

Chapter:
1
Remote Care
Chapter:
2
The Race to Return Safe
Chapter:
3
Realigning in Real Time
Chapter:
4
Post-Surge Capacity
Chapter:
5
The Next Normal
Chapter:
6
Fast Launch; Long Tail

Pages

  • 1
  • 2
  • next ›
  • last »
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries.

Contact Us
Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2021 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Privacy Shield
  • Online Tracking Opt-Out